Q80326 (Q80326): Difference between revisions
Jump to navigation
Jump to search
(Created claim: summary (P836): The aim of the project is to develop the existing R & D Department at Biofarm by purchasing new equipment and equipment to carry out research and development work for the development of innovative medicinal products. The implementation will contribute to strengthening Biofarm’s R & D potential, which is consistent with the company’s goal and direction of development, which is to constantly expand its offer with ever better, innovative products....) |
(Changed label, description and/or aliases in 1 language: remove_english_label) |
||
| label / en | label / en | ||
Revision as of 11:54, 14 October 2020
Project in Poland financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project in Poland financed by DG Regio |
Statements
799,125.0 zloty
0 references
3,196,500.0 zloty
0 references
25.0 percent
0 references
1 May 2019
0 references
31 December 2020
0 references
BIOFARM SP. Z O.O.
0 references
52°24'2.2"N, 16°55'11.3"E
0 references
Celem projektu jest rozwój istniejącego w firmie Biofarm Działu badawczo-rozwojowego, przez zakup nowej aparatury i sprzętu, która służyć będzie prowadzeniu prac badawczo-rozwojowych na rzecz tworzenia innowacyjnych produktów leczniczych. Realizacja przyczyni się do wzmocnienie potencjału firmy Biofarm do prowadzenia działalności B+R, co jest zgodne z celem i kierunkiem rozwoju firmy, jakim jest stałe rozszerzanie oferty o coraz lepsze, innowacyjne produkty. Wymaga to stałego rozwijania prac badawczych i technologicznych, wdrażania nowych i udoskonalania stosowanych technologii, co pozwoli wytwarzać nowoczesne i bezpieczne dla pacjentów produkty lecznicze zgodnie ze standardami farmaceutycznymi. (Polish)
0 references
The aim of the project is to develop the existing R & D Department at Biofarm by purchasing new equipment and equipment to carry out research and development work for the development of innovative medicinal products. The implementation will contribute to strengthening Biofarm’s R & D potential, which is consistent with the company’s goal and direction of development, which is to constantly expand its offer with ever better, innovative products. This requires the continuous development of research and technology, the implementation of new technologies and the improvement of the technologies used to produce modern and safe medicinal products in accordance with pharmaceutical standards. (English)
14 October 2020
0 references
Identifiers
POIR.02.01.00-00-0005/19
0 references